Associated Papers
Mono and biallelic variants in HCN2 cause severe neurodevelopmental disorders.
Houdayer C et al.
Medrxiv : the Preprint Server for Health Sciences, 2024
The Contribution of HCN Channelopathies in Different Epileptic Syndromes, Mechanisms, Modulators, and Potential Treatment Targets: A Systematic Review.
Kessi M et al.
Frontiers in Molecular Neuroscience, 2022
Case-control pharmacogenetic study of HCN1/HCN2 variants and genetic generalized epilepsies.
Wu SZ et al.
Clinical and Experimental Pharmacology & Physiology, 2018
Gain-of-function HCN2 variants in genetic epilepsy.
Li M et al.
Human Mutation, 2018
Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy.
Wei F et al.
Neuroscience Bulletin, 2017
HCN channelopathies: pathophysiology in genetic epilepsy and therapeutic implications.
Reid CA et al.
British Journal of Pharmacology, 2012
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy.
DiFrancesco JC et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2011
Genetic analysis of hyperpolarization-activated cyclic nucleotide-gated cation channels in sudden unexpected death in epilepsy cases.
Tu E et al.
Brain Pathology (zurich, Switzerland), 2011
Mutation analysis of the hyperpolarization-activated cyclic nucleotide-gated channels HCN1 and HCN2 in idiopathic generalized epilepsy.
Tang B et al.
Neurobiology of Disease, 2008
Select a paper to view details